Svenska Handelsbanken ser. B (0R7S)
London Exchange · UK · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 230.60 |
|---|---|
| 52-week range | 201.90 – 250.40 |
| Return, 1 month / 3 months | −4.9% / +2.4% |
| Return, 1 year / 3 years | +13.9% / +120.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 23.3% |
| Worst drawdown (1 year) | -15.1% |
| Average daily value traded | 0.23M SEK |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Svenska Handelsbanken is a Swedish bank based in Stockholm. It provides retail and corporate banking through a network of local branches, offering mortgages, savings accounts, loans and payment services to households and small and medium-sized businesses. The bank also serves larger corporate clients and offers asset management and life insurance products. Its operations are concentrated in Sweden and the other Nordic countries, with additional banking activities in the United Kingdom and the Netherlands.
The shares are listed on the London Exchange in UK under the code 0R7S, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Svenska Handelsbanken ser. B (0R7S) trades on the London Exchange in UK. It last closed at SEK 230.60 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,054 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.9% and over the last three months it rose 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -7.9% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.4% | ||
| 6-month return | 4.1% | ||
| 12-month return, skipping the last month | 19.7% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.1% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.23M SEK | ||
| Zero-volume days | 3.3% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −4.9% |
| 3 months | +2.4% |
| 6 months | +4.1% |
| 1 year | +13.9% |
| 3 years | +120.7% |
| 5 years | +155.1% |
Signals
| 50-day / 200-day average | 237.34 / 228.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | SEK 8.0000 |
| 27 Mar 2025 | SEK 7.5000 |
| 21 Mar 2024 | SEK 6.5000 |
| 23 Mar 2023 | SEK 2.5000 |
| 24 Mar 2022 | SEK 5.0000 |
| 25 Mar 2021 | SEK 0.9133 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.